Suven Life Sciences Ltd SUVEN-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 3:24 PM IST
79.05quote price arrow down-1.30 (-1.62%)
Volume
129,664
52 week range
71.80 - 124.45
Loading...
  • Open80.50
  • Day High81.80
  • Day Low78.55
  • Prev Close80.35
  • 52 Week High124.45
  • 52 Week High Date10/08/21
  • 52 Week Low71.80
  • 52 Week Low Date03/08/22

Key Stats

  • Market Cap150.34M
  • Shares Out145.38M
  • 10 Day Average Volume198,285.8
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-11.18

KEY STATS

  • Open80.50
  • Day High81.80
  • Day Low78.55
  • Prev Close80.35
  • 52 Week High124.45
  • 52 Week High Date10/08/21
  • 52 Week Low71.80
  • 52 Week Low Date03/08/22
  • Market Cap150.34M
  • Shares Out145.38M
  • 10 Day Average Volume198,285.8
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-11.18

RATIOS/PROFITABILITY

  • EPS (TTM)-9.58
  • P/E (TTM)-8.25
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date02/14/2019
  • Div Amount1.50
  • Split Date-
  • Split Factor-

Latest On Suven Life Sciences Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Suven Life Sciences Limited is a pharmaceutical company engaged in the business of manufacture and sale of bulk drugs and intermediaries. The Company is focused on discovering and developing new chemical entities (NCEs), which are central nervous system therapies for the treatment of cognitive disorders, depressive disorders, sleep disorders, psychiatric disorders, pain and inflammation, gastrointestinal motility disorders. Its research targets include serotonin 6 receptor...
Venkateswarlu Jasti
Executive Chairman of the Board, Chief Executive Officer
M. Mohan Kumar
Chief Financial Officer
Address
SDE Serene Chambers 6th Floor
Road No. 5 Avenue 7, Banjara Hills
Hyderabad
500034
India